These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36206661)

  • 1. Comprehensive analysis of PLKs expression and prognosis in breast cancer.
    Jiawei W; Xiajun B; Tian S; Xuzheng G; Zhenwang Z
    Cancer Genet; 2022 Nov; 268-269():83-92. PubMed ID: 36206661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analyses of expressions and prognostic values of Polo-like kinases in non-small cell lung cancer.
    Zeng Y; Li N; Liu W; Zeng M; Cheng J; Huang J
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2447-2460. PubMed ID: 32627077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-mitotic functions of polo-like kinases in cancer cells.
    Raab CA; Raab M; Becker S; Strebhardt K
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188467. PubMed ID: 33171265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis.
    Pezuk JA; Brassesco MS; de Oliveira RS; Machado HR; Neder L; Scrideli CA; Tone LG
    Childs Nerv Syst; 2017 Apr; 33(4):609-615. PubMed ID: 28283778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-Dependent and cell specific epigenetic regulation of the polo-like kinases under oxidative stress.
    Ward A; Hudson JW
    PLoS One; 2014; 9(1):e87918. PubMed ID: 24498222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Expression of
    Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
    Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
    Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
    J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the Functions of Polo-Like Kinases in Mice and Their Applications as Cancer Targets with a Special Focus on Ovarian Cancer.
    Kressin M; Fietz D; Becker S; Strebhardt K
    Cells; 2021 May; 10(5):. PubMed ID: 34065956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile.
    Deng S; Lu X; Zhang Z; Meng R; Li M; Xia S
    J Cell Mol Med; 2021 Jul; 25(14):6652-6663. PubMed ID: 34080290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic values and immune characteristics of polo-like kinases (PLKs) family: A pan-cancer multi-omics analysis.
    Shen C; Wang T; Li K; Fu C; Yang S; Zhang Z; Wu Z; Li Z; Li Z; Lin Y; Zhang Y; Guo J; Fan Z; Hu H
    Heliyon; 2024 Apr; 10(7):e28048. PubMed ID: 38560150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma.
    Ding Y; Liu H; Zhang C; Bao Z; Yu S
    Aging (Albany NY); 2022 Mar; 14(5):2320-2334. PubMed ID: 35256538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma.
    Pellegrino R; Calvisi DF; Ladu S; Ehemann V; Staniscia T; Evert M; Dombrowski F; Schirmacher P; Longerich T
    Hepatology; 2010 Mar; 51(3):857-68. PubMed ID: 20112253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polo-like kinases and acute leukemia.
    Goroshchuk O; Kolosenko I; Vidarsdottir L; Azimi A; Palm-Apergi C
    Oncogene; 2019 Jan; 38(1):1-16. PubMed ID: 30104712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a PLK1-based immune risk model for prognosis and treatment response prediction in breast cancer.
    Chen Y; You Y; Wu Q; Wu J; Lin S; Sun Y; Cui Z
    Cancer Med; 2023 May; 12(9):11020-11039. PubMed ID: 36951624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polo-like kinases and oncogenesis.
    Eckerdt F; Yuan J; Strebhardt K
    Oncogene; 2005 Jan; 24(2):267-76. PubMed ID: 15640842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polo-like kinase 1 (PLK1) is involved in toll-like receptor (TLR)-mediated TNF-α production in monocytic THP-1 cells.
    Hu J; Wang G; Liu X; Zhou L; Jiang M; Yang L
    PLoS One; 2013; 8(10):e78832. PubMed ID: 24205328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SmSak, the second Polo-like kinase of the helminth parasite Schistosoma mansoni: conserved and unexpected roles in meiosis.
    Long T; Vanderstraete M; Cailliau K; Morel M; Lescuyer A; Gouignard N; Grevelding CG; Browaeys E; Dissous C
    PLoS One; 2012; 7(6):e40045. PubMed ID: 22768216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of polo-like kinases in retinoblastoma: correlation with patient outcome, clinical and histopathological parameters.
    Singh L; Pushker N; Sen S; Singh MK; Chauhan FA; Kashyap S
    Clin Exp Ophthalmol; 2015 Aug; 43(6):550-7. PubMed ID: 25754767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
    Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
    Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic analysis of the expression levels and prognosis of breast cancer-related cadherins.
    Xu M; Liu C; Pu L; Lai J; Li J; Ning Q; Liu X; Deng S
    Exp Biol Med (Maywood); 2021 Aug; 246(15):1706-1720. PubMed ID: 33899544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.